Join Dr. Tom Babic, a board-certified neurologist with 40+ years of clinical research experience, as he discusses the complexities of early Parkinson’s disease (PD) research.
In this on-demand webinar, Dr. Babic explores the challenges and recent advancements in drug development for early-stage PD, including ethical considerations of postponing symptomatic treatment and the significance of patient engagement in clinical trials.
Watch today to gain insights into treatment modalities, strategies for disease modification, evolving endpoints and biomarkers, and more.
